Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
As one of rate-limiting enzyme in the Krebs cycle, whether high expression of IDH3a affects glucose uptake in tumors has not been elucidated.
|
31355526 |
2019 |
Adenocarcinoma of lung (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
IDH3a targets AKT-GLUT1 pathway to affect glucose uptake and metabolites in lung adenocarcinoma.
|
31355526 |
2019 |
Glaucoma, Primary Open Angle
|
0.010 |
Biomarker
|
disease |
BEFREE |
The most abundant proteins in POAG subjects are IGKC (13.56-fold), ITIH4 (4.1-fold), APOC3 (3.36-fold), IDH3A (3.11-fold), LOC105369216 (2.98-fold).
|
29847670 |
2018 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
IDH3A now joins the list of TCA cycle-related proteins, which includes ACO2, DLD, SLC25A19, FH, and succinate dehydrogenase subunits, all associated with neurological disorders.
|
28058510 |
2017 |
Encephalopathies
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Homozygous mutation, p.Pro304His, in IDH3A, encoding isocitrate dehydrogenase subunit is associated with severe encephalopathy in infancy.
|
28058510 |
2017 |
Bipolar Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggest that abnormality in the metabolism of isocitrate by IDH3A in the mitochondria plays a key role in the pathogenesis of BD, supporting the mitochondrial dysfunction hypothesis of BD.
|
26782057 |
2016 |
Autosomal recessive retinitis pigmentosa
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A novel missense variant in IDH3A causes autosomal recessive retinitis pigmentosa.
|
31012789 |
2019 |
Autosomal recessive retinitis pigmentosa
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
IDH3A variants were identified as a novel cause of typical arRP in some individuals associated with macular pseudocoloboma.
|
28412069 |
2017 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Glaucoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Conductive hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperinsulinism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypogonadism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Keratoconus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Obesity
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ophthalmoplegia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Optic Atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Photophobia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital hypoplasia of penis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blindness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electroretinogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|